The quarter was only slightly ahead of the bar, not a clean beat. Adjusted EPS was $0.58 versus a published consensus of approximately $0.57, while sales fell 3.0% year over year to $1.824 billion and adjusted operating income declined 3.5% to $216.6 million (Financial Highlights; Adjusted Operating Income table). The headline EPS improvement was helped by lower interest expense and a much lighter tax burden, rather than broad-based revenue growth.
| Metric | Q2 2026 | Q2 2025 / expectation | Read |
|---|---|---|---|
| Net sales | $1,823.5 million | $1,880.8 million | Down 3.0% (Income Statement) |
| Adjusted EPS | $0.58 | $0.53; published consensus ~$0.57 | Narrow beat (Financial Highlights; Adjusted Net Income and Adjusted EPS) |
| Adjusted operating income | $216.6 million | $224.4 million | Down 3.5% (Adjusted Operating Income table) |
| FY 2026 adjusted EPS guidance | $2.85–$3.15 | Prior $3.00–$3.40 | Range cut; midpoint falls from $3.20 to $3.00 |
| Leverage | 2.99x | 3.56x in prior-year period | Improved (Credit Facility Leverage reconciliation) |
The main change is the guidance reset. The new $2.85–$3.15 full-year adjusted EPS range is below the prior $3.00–$3.40 range, cutting the midpoint by 6.25%. That is a worse forward earnings trajectory than the market had been carrying, and it outweighs a quarterly adjusted-EPS result that beat consensus by only about one cent.
The operating mix is uneven, with the retail side still under pressure. Mattress Firm sales declined 2.8%, same-store sales were only slightly positive, and adjusted operating margin fell to 6.5% from 7.8% because of weaker mix, higher consumer-financing costs, store investment and deleverage (Segment Results — Mattress Firm). North American manufacturing margins improved sharply to 26.7% from 22.7%, but reported sales declined 5.7%; international sales grew just 1.3% on a constant-currency basis while margin slipped to 47.4% (Segment Results — Tempur Sealy North America; Segment Results — Tempur Sealy International).
Balance-sheet progress is a genuine offset, but not enough to change the earnings read. Operating cash flow reached $482.8 million in the first six months versus $292.5 million a year earlier, and leverage improved to 2.99x as debt repayments reduced long-term debt to $4.293 billion from $4.573 billion at year-end (Cash Flow Statement; Balance Sheet; Credit Facility Leverage reconciliation). That improves financial flexibility, but the filing's most important incremental signal is still the lower earnings outlook amid soft sales and compressed Mattress Firm profitability.
Read the original 8-K on SEC EDGAR ↗